Skip to main content
OpenTrials

Clinical trial condition

Dermatitis, Atopic

Explore clinical trials studying Dermatitis, Atopic. Study availability and eligibility vary by location and protocol.

1,194 public trials 150 recruiting studies
Refine in advanced search Browse all conditions

Dermatitis, Atopic trial results

Completed

Phase 2b Study to Evaluate the Efficacy and Safety of ISB 830 in Adults With Moderate to Severe Atopic Dermatitis

NCT03568162

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +9 more
Locations
  • Ichnos Investigational Site 129 Birmingham, Alabama, United States
  • Ichnos Investigational Site 120 Clovis, California, United States
  • Ichnos Investigational Site 105 Rolling Hills Estates, California, United States
  • Ichnos Investigational Site 106 Bridgeport, Connecticut, United States
View all 83 locations
View Trial Details
Completed

A Study of AK120 (IL-4Rα) in Healthy Subjects and Subjects With Moderate- to- Severe Atopic Dermatitis

NCT04256174

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Emeritus Sydney Botany, New South Wales, Australia
  • Emeritus Melbourne Camberwell, Victoria, Australia
  • CMAX Clinical Research Adelaide, Australia
  • Sinclair Dermatology East Melbourne, Australia
View all 13 locations
View Trial Details
Completed

Safety, Pharmacokinetics and Efficacy of Dupilumab in Patients ≥6 Months to <6 Years With Moderate-to-Severe Atopic Dermatitis (Liberty AD PRESCHOOL)

NCT03346434

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +9 more
Locations
  • Regeneron Investigational Site Birmingham, Alabama, United States
  • Regeneron Investigational Site Gilbert, Arizona, United States
  • Regeneron Investigational Site Long Beach, California, United States
  • Regeneron Investigational site Los Angeles, California, United States
View all 48 locations
View Trial Details
Completed

Study of TER-101 Topical Ointment in Subjects With Atopic Dermatitis

NCT04753034

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Teres Bio site 05 Scottsdale, Arizona, United States
  • Teres Bio Site 04 Encinitas, California, United States
  • Teres Bio Site 12 North Miami Beach, Florida, United States
  • Teres Bio Site 10 Tampa, Florida, United States
View Trial Details
Completed

Efficacy and Safety Study of CD2027 Ointment 3 Microgram Per Gram (mcg/g) Twice Daily Treatment for Adults With at Least Moderate Atopic Dermatitis

NCT00919763

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Burke Pharmaceutical Research Hot Springs, Arkansas, United States
  • Therapeutics Clinical Research, Inc. San Diego, California, United States
  • Colorado Medical Research Center, Inc. Denver, Colorado, United States
  • Longmont Medical Research Network Longmont, Colorado, United States
View all 14 locations
View Trial Details
Completed

Study of Abrocitinib Compared With Dupilumab in Adults With Moderate to Severe Atopic Dermatitis on Background Topical Therapy

NCT04345367

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
Locations
  • Total Skin & Beauty Dermatology Center, PC Birmingham, Alabama, United States
  • Clinical Research Center Of Alabama Birmingham, Alabama, United States
  • Alliance Dermatology & MOHS Center, PC Phoenix, Arizona, United States
  • First OC Dermatology Fountain Valley, California, United States
View all 151 locations
View Trial Details
Completed

Crisaborole for Chinese and Japanese Subjects (≥2 Years of Age) With Mild to Moderate Atopic Dermatitis

NCT04360187

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Beijing Friendship Hospital, Capital Medical University Beijing, Beijing Municipality, China
  • Dermatology Hospital of Southern Medical University Guangzhou, Guangdong, China
  • Guangzhou First People's Hospital Guangzhou, Guangdong, China
  • The Second Affiliated Hospital of Guangzhou Medical University Guangzhou, Guangdong, China
View all 39 locations
View Trial Details

Related conditions